Ad
related to: what happened to regeneron stock trading
Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...
Regeneron (REGN) closed the most recent trading day at $735.96, moving -0.01% from the previous trading session.
In the latest trading session, Regeneron (REGN) closed at $747.33, marking a +1.38% move from the previous day.
In the latest trading session, Regeneron (REGN) closed at $547.12, marking a +0.49% move from the previous day.
Regeneron (REGN) closed at $594.90 in the latest trading session, marking a -0.28% move from the prior day.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
In the latest trading session, Regeneron (REGN) closed at $630.31, marking a -1.13% move from the previous day.
Ad
related to: what happened to regeneron stock trading